Disclosed are compositions and methods related to the interaction of polyCUG and polyCCUG repeat RNA and proteins that bind to these repetitive RNA sequences. Also disclosed are methods of treating DM1 or DM2 comprising inhibiting the interaction of poly(CUG) exp or poly(CCUG) exp RNA with muscleblind proteins, or by causing improvement of spliceopathy in myotonic dystrophy.